- Home
- ICCC vs LGCL Comparison
ICCC vs LGCL Comparison
Compare ICCC & LGCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- LGCL
- Stock Information
- Founded
- ICCC 1982
- LGCL 2009
- Country
- ICCC United States
- LGCL China
- Employees
- ICCC N/A
- LGCL N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- LGCL
- Sector
- ICCC Health Care
- LGCL
- Exchange
- ICCC Nasdaq
- LGCL NYSE
- Market Cap
- ICCC 45.9M
- LGCL 48.3M
- IPO Year
- ICCC 1987
- LGCL 2024
- Fundamental
- Price
- ICCC $5.11
- LGCL $0.55
- Analyst Decision
- ICCC
- LGCL
- Analyst Count
- ICCC 0
- LGCL 0
- Target Price
- ICCC N/A
- LGCL N/A
- AVG Volume (30 Days)
- ICCC 10.1K
- LGCL 98.9K
- Earning Date
- ICCC 02-25-2025
- LGCL 11-22-2024
- Dividend Yield
- ICCC N/A
- LGCL N/A
- EPS Growth
- ICCC N/A
- LGCL 11.49
- EPS
- ICCC N/A
- LGCL 0.14
- Revenue
- ICCC $23,838,001.00
- LGCL $173,306,912.00
- Revenue This Year
- ICCC N/A
- LGCL N/A
- Revenue Next Year
- ICCC N/A
- LGCL N/A
- P/E Ratio
- ICCC N/A
- LGCL $4.15
- Revenue Growth
- ICCC 46.37
- LGCL N/A
- 52 Week Low
- ICCC $3.34
- LGCL $0.47
- 52 Week High
- ICCC $5.82
- LGCL $5.00
- Technical
- Relative Strength Index (RSI)
- ICCC 52.70
- LGCL N/A
- Support Level
- ICCC $4.86
- LGCL N/A
- Resistance Level
- ICCC $5.50
- LGCL N/A
- Average True Range (ATR)
- ICCC 0.36
- LGCL 0.00
- MACD
- ICCC -0.03
- LGCL 0.00
- Stochastic Oscillator
- ICCC 39.06
- LGCL 0.00
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.